UniProt ID | CNOT2_HUMAN | |
---|---|---|
UniProt AC | Q9NZN8 | |
Protein Name | CCR4-NOT transcription complex subunit 2 | |
Gene Name | CNOT2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 540 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. Required for the CCR4-NOT complex structural integrity. Can repress transcription and may link the CCR4-NOT complex to transcriptional regulation; the repressive function may specifically involve the N-Cor repressor complex containing HDAC3, NCOR1 and NCOR2. Involved in the maintenance of emryonic stem (ES) cell identity.. | |
Protein Sequence | MVRTDGHTLSEKRNYQVTNSMFGASRKKFVEGVDSDYHDENMYYSQSSMFPHRSEKDMLASPSTSGQLSQFGASLYGQQSALGLPMRGMSNNTPQLNRSLSQGTQLPSHVTPTTGVPTMSLHTPPSPSRGILPMNPRNMMNHSQVGQGIGIPSRTNSMSSSGLGSPNRSSPSIICMPKQQPSRQPFTVNSMSGFGMNRNQAFGMNNSLSSNIFNGTDGSENVTGLDLSDFPALADRNRREGSGNPTPLINPLAGRAPYVGMVTKPANEQSQDFSIHNEDFPALPGSSYKDPTSSNDDSKSNLNTSGKTTSSTDGPKFPGDKSSTTQNNNQQKKGIQVLPDGRVTNIPQGMVTDQFGMIGLLTFIRAAETDPGMVHLALGSDLTTLGLNLNSPENLYPKFASPWASSPCRPQDIDFHVPSEYLTNIHIRDKLAAIKLGRYGEDLLFYLYYMNGGDVLQLLAAVELFNRDWRYHKEERVWITRAPGMEPTMKTNTYERGTYYFFDCLNWRKVAKEFHLEYDKLEERPHLPSTFNYNPAQQAF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Ubiquitination | DGHTLSEKRNYQVTN CCCCCCCCCCHHHHH | 42.44 | - | |
15 | Phosphorylation | TLSEKRNYQVTNSMF CCCCCCCHHHHHHCC | 14.37 | 27642862 | |
20 | Phosphorylation | RNYQVTNSMFGASRK CCHHHHHHCCCCCHH | 13.21 | 28555341 | |
35 | Phosphorylation | KFVEGVDSDYHDENM HHHHCCCCCCCCCCC | 37.35 | 28796482 | |
37 | Phosphorylation | VEGVDSDYHDENMYY HHCCCCCCCCCCCCC | 18.34 | 28796482 | |
43 | Phosphorylation | DYHDENMYYSQSSMF CCCCCCCCCCCCCCC | 16.14 | 28796482 | |
44 | Phosphorylation | YHDENMYYSQSSMFP CCCCCCCCCCCCCCC | 6.89 | 28796482 | |
45 | Phosphorylation | HDENMYYSQSSMFPH CCCCCCCCCCCCCCC | 13.19 | 28796482 | |
47 | Phosphorylation | ENMYYSQSSMFPHRS CCCCCCCCCCCCCCC | 20.17 | 28796482 | |
48 | Phosphorylation | NMYYSQSSMFPHRSE CCCCCCCCCCCCCCH | 19.46 | 28796482 | |
54 | Phosphorylation | SSMFPHRSEKDMLAS CCCCCCCCHHHCCCC | 46.06 | 27251275 | |
56 | Acetylation | MFPHRSEKDMLASPS CCCCCCHHHCCCCCC | 50.08 | 7467815 | |
61 | Phosphorylation | SEKDMLASPSTSGQL CHHHCCCCCCCCHHH | 18.54 | 28450419 | |
63 | Phosphorylation | KDMLASPSTSGQLSQ HHCCCCCCCCHHHHH | 32.48 | 28450419 | |
64 | Phosphorylation | DMLASPSTSGQLSQF HCCCCCCCCHHHHHH | 40.02 | 28450419 | |
65 | Phosphorylation | MLASPSTSGQLSQFG CCCCCCCCHHHHHHC | 28.95 | 28450419 | |
69 | Phosphorylation | PSTSGQLSQFGASLY CCCCHHHHHHCHHHH | 18.64 | 28450419 | |
74 | Phosphorylation | QLSQFGASLYGQQSA HHHHHCHHHHHHHHC | 23.62 | 27080861 | |
76 | Phosphorylation | SQFGASLYGQQSALG HHHCHHHHHHHHCCC | 15.47 | 27080861 | |
80 | Phosphorylation | ASLYGQQSALGLPMR HHHHHHHHCCCCCCC | 19.99 | 27080861 | |
87 | Methylation | SALGLPMRGMSNNTP HCCCCCCCCCCCCCH | 35.40 | 115389015 | |
89 | Sulfoxidation | LGLPMRGMSNNTPQL CCCCCCCCCCCCHHH | 2.46 | 21406390 | |
90 | Phosphorylation | GLPMRGMSNNTPQLN CCCCCCCCCCCHHHH | 29.74 | 30243723 | |
93 | Phosphorylation | MRGMSNNTPQLNRSL CCCCCCCCHHHHHHH | 19.36 | 29255136 | |
99 | Phosphorylation | NTPQLNRSLSQGTQL CCHHHHHHHHCCCCC | 31.16 | 26055452 | |
101 | Phosphorylation | PQLNRSLSQGTQLPS HHHHHHHHCCCCCCC | 28.01 | 17525332 | |
104 | Phosphorylation | NRSLSQGTQLPSHVT HHHHHCCCCCCCCCC | 21.21 | 28450419 | |
108 | Phosphorylation | SQGTQLPSHVTPTTG HCCCCCCCCCCCCCC | 38.90 | 28450419 | |
111 | Phosphorylation | TQLPSHVTPTTGVPT CCCCCCCCCCCCCCC | 14.97 | 21712546 | |
113 | O-linked_Glycosylation | LPSHVTPTTGVPTMS CCCCCCCCCCCCCEE | 27.15 | 30059200 | |
113 | Phosphorylation | LPSHVTPTTGVPTMS CCCCCCCCCCCCCEE | 27.15 | 25394399 | |
114 | Phosphorylation | PSHVTPTTGVPTMSL CCCCCCCCCCCCEEC | 37.07 | 28450419 | |
118 | Phosphorylation | TPTTGVPTMSLHTPP CCCCCCCCEECCCCC | 19.58 | 21082442 | |
120 | Phosphorylation | TTGVPTMSLHTPPSP CCCCCCEECCCCCCC | 21.34 | 21712546 | |
123 | Phosphorylation | VPTMSLHTPPSPSRG CCCEECCCCCCCCCC | 42.03 | 26055452 | |
126 | Phosphorylation | MSLHTPPSPSRGILP EECCCCCCCCCCCCC | 36.39 | 26055452 | |
128 | Phosphorylation | LHTPPSPSRGILPMN CCCCCCCCCCCCCCC | 47.69 | 30177828 | |
137 | Methylation | GILPMNPRNMMNHSQ CCCCCCHHHCCCHHH | 38.38 | 115485459 | |
141 (in isoform 3) | Ubiquitination | - | 22.38 | 21906983 | |
143 | Phosphorylation | PRNMMNHSQVGQGIG HHHCCCHHHCCCCCC | 22.89 | 28857561 | |
155 | Phosphorylation | GIGIPSRTNSMSSSG CCCCCCCCCCCCCCC | 35.66 | 23927012 | |
157 | Phosphorylation | GIPSRTNSMSSSGLG CCCCCCCCCCCCCCC | 21.30 | 23401153 | |
159 | Phosphorylation | PSRTNSMSSSGLGSP CCCCCCCCCCCCCCC | 22.60 | 23927012 | |
160 | Phosphorylation | SRTNSMSSSGLGSPN CCCCCCCCCCCCCCC | 21.56 | 23401153 | |
161 | Phosphorylation | RTNSMSSSGLGSPNR CCCCCCCCCCCCCCC | 30.63 | 23401153 | |
165 | Phosphorylation | MSSSGLGSPNRSSPS CCCCCCCCCCCCCCC | 24.84 | 19664994 | |
169 | O-linked_Glycosylation | GLGSPNRSSPSIICM CCCCCCCCCCCEEEE | 53.92 | 30059200 | |
169 | Phosphorylation | GLGSPNRSSPSIICM CCCCCCCCCCCEEEE | 53.92 | 23401153 | |
170 | Phosphorylation | LGSPNRSSPSIICMP CCCCCCCCCCEEEEC | 21.30 | 22167270 | |
172 | Phosphorylation | SPNRSSPSIICMPKQ CCCCCCCCEEEECCC | 26.91 | 22167270 | |
190 | Phosphorylation | RQPFTVNSMSGFGMN CCCCEEECCCCCCCC | 15.25 | 28555341 | |
242 | Phosphorylation | DRNRREGSGNPTPLI HCCCCCCCCCCCCCC | 30.55 | 29255136 | |
246 | Phosphorylation | REGSGNPTPLINPLA CCCCCCCCCCCCCCC | 34.42 | 25159151 | |
258 | Phosphorylation | PLAGRAPYVGMVTKP CCCCCCCEEEEEECC | 14.51 | 24275569 | |
270 | Phosphorylation | TKPANEQSQDFSIHN ECCCCCCCCCCCCCC | 26.07 | 23312004 | |
274 | Phosphorylation | NEQSQDFSIHNEDFP CCCCCCCCCCCCCCC | 31.09 | 28555341 | |
286 | Phosphorylation | DFPALPGSSYKDPTS CCCCCCCCCCCCCCC | 28.67 | 25627689 | |
293 | Phosphorylation | SSYKDPTSSNDDSKS CCCCCCCCCCCCCCC | 32.31 | - | |
294 | Phosphorylation | SYKDPTSSNDDSKSN CCCCCCCCCCCCCCC | 46.91 | - | |
299 | Acetylation | TSSNDDSKSNLNTSG CCCCCCCCCCCCCCC | 50.81 | 7960613 | |
304 | Phosphorylation | DSKSNLNTSGKTTSS CCCCCCCCCCCCCCC | 41.86 | 29214152 | |
305 | Phosphorylation | SKSNLNTSGKTTSST CCCCCCCCCCCCCCC | 36.90 | 28985074 | |
307 | Ubiquitination | SNLNTSGKTTSSTDG CCCCCCCCCCCCCCC | 48.69 | - | |
308 | Phosphorylation | NLNTSGKTTSSTDGP CCCCCCCCCCCCCCC | 35.12 | 21712546 | |
309 | Phosphorylation | LNTSGKTTSSTDGPK CCCCCCCCCCCCCCC | 24.94 | 28348404 | |
310 | Phosphorylation | NTSGKTTSSTDGPKF CCCCCCCCCCCCCCC | 36.15 | 28348404 | |
311 | Phosphorylation | TSGKTTSSTDGPKFP CCCCCCCCCCCCCCC | 28.55 | 28348404 | |
312 | Phosphorylation | SGKTTSSTDGPKFPG CCCCCCCCCCCCCCC | 44.75 | 28348404 | |
315 (in isoform 2) | Ubiquitination | - | 37.61 | 21906983 | |
321 | Ubiquitination | GPKFPGDKSSTTQNN CCCCCCCCCCCCCCC | 52.82 | - | |
380 | Phosphorylation | MVHLALGSDLTTLGL CEEEECCCCCEEECC | 30.23 | 20068231 | |
383 | Phosphorylation | LALGSDLTTLGLNLN EECCCCCEEECCCCC | 25.60 | 20068231 | |
384 | Phosphorylation | ALGSDLTTLGLNLNS ECCCCCEEECCCCCC | 26.56 | 20068231 | |
391 | Phosphorylation | TLGLNLNSPENLYPK EECCCCCCHHHCCCC | 36.44 | 29523821 | |
396 | Phosphorylation | LNSPENLYPKFASPW CCCHHHCCCCCCCCC | 18.89 | 20090780 | |
401 | Phosphorylation | NLYPKFASPWASSPC HCCCCCCCCCCCCCC | 24.90 | 28348404 | |
405 | Phosphorylation | KFASPWASSPCRPQD CCCCCCCCCCCCCCC | 30.83 | 25159151 | |
406 | Phosphorylation | FASPWASSPCRPQDI CCCCCCCCCCCCCCC | 21.92 | 25159151 | |
440 (in isoform 5) | Ubiquitination | - | 22.15 | 21906983 | |
471 | Phosphorylation | LFNRDWRYHKEERVW HHCCCCCCCCCCCEE | 17.00 | 24719451 | |
480 | Phosphorylation | KEERVWITRAPGMEP CCCCEEEEECCCCCC | 12.69 | 24719451 | |
490 | Ubiquitination | PGMEPTMKTNTYERG CCCCCCCCCCCEECC | 40.89 | 2190698 | |
490 (in isoform 1) | Ubiquitination | - | 40.89 | 21906983 | |
494 | Phosphorylation | PTMKTNTYERGTYYF CCCCCCCEECCEEEE | 13.00 | 30576142 | |
499 | Phosphorylation | NTYERGTYYFFDCLN CCEECCEEEEEEECC | 10.91 | 30576142 | |
500 | Phosphorylation | TYERGTYYFFDCLNW CEECCEEEEEEECCH | 9.52 | - | |
512 | Ubiquitination | LNWRKVAKEFHLEYD CCHHHHHHHHCCCHH | 64.99 | - | |
520 | Ubiquitination | EFHLEYDKLEERPHL HHCCCHHHHHCCCCC | 57.82 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
101 | S | Phosphorylation | Kinase | ATR | Q13535 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CNOT2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CNOT2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126 AND SER-165, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-93 AND SER-165, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-101, AND MASSSPECTROMETRY. |